New research identifies oxidative stress, DNA damage, genetic variants, and stem cell depletion as key drivers of hair graying, with emerging therapies under investigation.
Pediatric vitiligo was linked to higher risks of sensorineural and mixed hearing loss, with a short-term elevated risk of certain retinal abnormalities, according to a large US-based cohort analysis.
In a phase II trial (Alliance A091802) reported in the Journal of Clinical Oncology, Zandberg et al investigated the survival benefit of adding cetuximab to avelumab in patients with advanced cutaneou...
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A new randomized trial using 3D imaging compared four botulinum toxin A formulations in women, revealing differences in onset and durability of glabellar wrinkle reduction over six months.
In a phase III trial (C-POST) reported at the 2025 ASCO Annual Meeting and in The New England Journal of Medicine, Rischin et al compared disease-free survival outcomes of adjuvant cemiplimab vs place...